Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues

Oral Oncology

Volumn 42, Issue 2, 2006, Pages 147-153

  Fan, Guo Kang ^a   Chen, Jun ^a   Ping, Feiyun ^a   Geng, Yanhua ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cancer; hsp60; Oral leukoplakia; p53; P57(kip2)

Indexed keywords

HEAT SHOCK PROTEIN 60; PROTEIN P53; PROTEIN P57;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; CHAPERONIN 60; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DISEASE PROGRESSION; HUMANS; LEUKOPLAKIA, ORAL; LYMPHATIC METASTASIS; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 30844452690     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.06.017     Document Type: Article

References (25)

1. M.H. Lee, and H.Y. Yang Negative regulators of cyclin-dependent kinases and their roles in cancers Cell Mol Life Sci 58 12-13 2001 1907 1922
2. X. Grana, and E.P. Reddy Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinase (CDKs), growth suppressor and cyclin dependent kinase inhibitors (CDKIs) Oncogene 11 2 1995 211 219
3. M.H. Lee, I. Reynisdottir, and J. Massague Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution Genes Dev 9 6 1995 639 649
4. S. Matsuoka, M.C. Edwards, C. Bai, S. Parker, P. Zhang, and A. Baldini p57KIP2 a structurally distinct member of the p21CIP1 cdk inhibitor family is a candidate tumor suppressor gene Genes Dev 9 6 1995 650 662
5. L. Sui, Y. Dong, M. Ohno, Y. Watanabe, K. Sugimoto, and M. Tokuda Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors Anticancer Res 22 6A 2002 3191 3196
6. J.Y. Shin, H.S. Kim, J. Park, J.B. Park, and J.Y. Lee Mechanism for inactivation of KIP family cyclin-dependent kinase inhibitor gene in gastric cancer cells Cancer Res 60 2 2000 262 265
7. J.Q. Li, F. Wu, H. Usuki, A. Kubo, T. Masaki, and J. Fujita Loss of p57KIP2 is associated with colorectal carcinogenesis Int J Oncol 23 6 2003 1537 1543
8. Y. Li, H. Nagai, T. Ohno, M. Yuge, S. Hatano, and E. Ito Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype Blood 100 7 2002 2572 2577
9. E.A. Slee, D.J. O'Connor, and X. Lu To die or not to die: how does p53 decide Oncogene 23 16 2004 2809 2818
10. I. Cruz, S.S. Napier, I. van der Waal, P.J. Snijders, J.M. Walboomers, and P.J. Lamey Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland J Clin Pathol 55 2 2002 98 104
11. H. Kurokawa, S. Matsumoto, T. Murata, Y. Yamashita, T. Tomoyose, and M. Zhang Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia J Oral Pathol Med 32 9 2003 513 521
12. J.J. Lee, W.K. Hong, W.N. Hittelman, L. Mao, R. Lotan, and D.M. Shin Predicting cancer development in oral leukoplakia: ten years of translational research Clin Cancer Res 6 5 2000 1702 1710
13. F. Cappello, M. Bellafiore, A. Palma, S. David, V. Marciano, and T. Bartolotta 60 KDa chaperonin (HSP60) is over-expressed during colorectal carcinogenesis Eur J Histochem 47 2 2003 105 110
14. P. Chaiyarit, A.H. Kafrawy, D.A. Miles, S.L. Zunt, M.L. Van Dis, and R.L. Gregory Oral lichen planus: an immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis J Oral Pathol Med 28 5 1999 210 215
15. M.R. Stampfer, J. Garbe, T. Nijjar, D. Wigington, K. Swisshelm, and P. Yaswen Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines Oncogene 22 34 2003 5238 5251
16. S. Rainier, L.A. Johnson, C.J. Dobry, A.J. Ping, P.E. Grundy, and A.P. Feinberg Relaxation of imprinted genes in human cancer Nature 362 6422 1993 747 749
17. A.P. Feinberg Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction Cancer Res 59 7 Suppl 1999 1743 1746
18. N. Pal, R.B. Wadey, B. Buckle, E. Yeomans, J. Pritchard, and J.K. Cowell Preferential loss of maternal alleles in sporadic Wilms' tumor Oncogene 5 11 1990 1665 1668
19. M. Kondo, S. Matsuoka, K. Uchida, H. Osada, M. Nagatake, and K. Takagi Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15 5 Oncogene 12 6 1996 1365 1368
20. W.T. Schroeder, L.Y. Chao, D.D. Dao, L.C. Strong, S. Pathak, and V. Riccardi Nonrandom loss of maternal chromosome 11 alleles in Wilms' tumors Am J Hum Genet 40 5 1987 413 420
21. S. Lai, H. Goepfert, A.M. Gillenwater, M.A. Luna, and A.K. El-Naggar Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma Clin Cancer Res 6 8 2000 3172 3176
22. M. Pagano, S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del Sal, and V. Chau Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 269 5244 1995 682 685
23. D. Oyake, H. Nishikawa, I. Koizuka, M. Fukuda, and T. Ohta Targeted substrate degradation by an engineered double RING ubiquitin ligase Biochem Biophys Res Commun 295 2 2002 370 375
24. M.P. Leibovitch, C. Kannengiesser, and S.A. Leibovitch Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site FEBS Lett 543 1-3 2003 125 128
25. T. Urano, H. Yashiroda, M. Muraoka, K. Tanaka, T. Hosoi, and S. Inoue p57Kip2 is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor β1 J Biol Chem 274 18 1999 12197 12200